Palabras clave
mesocorticolimbic system
dopamine
therapeutic generalities
Adicción
sistema mesocorticolimbico
dopamina
generalidades terapéuticas
Cómo citar
Resumen
El abuso de drogas es una enfermedad caracterizada por la urgencia de obtener y consumir una sustancia determinada independientemente de sus consecuencias negativas. Existen factores biológicos, sociales y psicológicos que predisponen a un individuo al abuso de drogas los adolescentes son los más vulnerables porque su cerebro no ha madurado completamente y están bajo presiones tanto sociales como psicológicas. Es por esto último que la prevención es aún más efectiva a esta edad. Las drogas de abuso alteran principalmente el sistema mesocorticolimbico; la dopamina y el glutamato desempeñan un papel importante en este circuito que normalmente median comportamientos de motivación. Se cree que las sustancias de abuso modifican este circuito usando mecanismos similares al aprendizaje normal resultando en aprendizaje disfuncional. Dichos cambios son a largo plazo y pueden ser evocados por eventos que recuerden la droga, en la ausencia de la misma. Un manejo multidisciplinario es necesario ya que el abuso de drogas tiene componentes biológicos, sociales y psicológicos. Las terapias cognitivas y comportamentales son comúnmente complementadas con agentes farmacológicos con los que se manejan los síntomas específicos de retirada y abstinencia.
Citas
Apodaca, TR. & Longabaugh, R. (2009) Mechanisms of change in motivational interviewing: a review and preliminary evaluation of the evidence. Addiction, 104, 705-715.
Baik, JH. (2013) Dopamine signaling in reward-related behaviors. Front Neural Circuits, 7, 152.
Carroll, KM., Easton, CJ., Nich, C., Hunkele, KA., Neavins, TM., Sinha, R., Ford, HL., Vitolo, SA., Doebrick, CA. & Rounsaville, BJ. (2006). The use of contingency management and motivational/skillsbuilding therapy to treat young adults with marijuana dependence. J Consult Clin Psychol, 74, 955-966.
Dahlstrom, A. & Fuxe, K. (1964). Localization of monoamines in the lower brain stem. Experientia, 20, 398-399.
Engle, B. (2011) Review: motivational interviewing reduces substance use compared with no treatment in substancedependent individuals. Evid Based Ment Health, 14, 116.
Everitt, BJ. & Robbins, TW. (2005). Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci, 8,1481-1489.
Georges, F. & Aston-Jones, G. (2002). Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons. J Neurosci, 22, 5173-5187.
Gogtay, N., Giedd, JN., Lusk, L., Hayashi, KM., Greenstein, D., Vaituzis, AC. … Thompson, PM. (2004). Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA, 101, 8174-8179.
Goldstein, RZ. & Volkow, ND. (2002). Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry, 159, 1642-1652.
Gould RW., Porrino LJ., Nader MA. (2012). Nonhuman Primate Models of Addiction and PET Imaging: Dopamine System Dysregulation. Curr Top Behav Neurosci, 11, 25-44.
Grace, AA., Floresco, SB., Goto, Y. & Lodge, DJ. (2007). Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci, 30, 220-227.
Habal, R. (2013). Heroin Toxicity. Retrieved from http://emedicine.medscape.com/article/166464-overview
Haile, CN., Mahoney, JJ., Newton, TF. & De La Garza, R., (2012). Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate. Pharmacol Ther, 134, 260-277.
Hyman, SE. (2005). Addiction: a disease of learning and memory. Am J Psychiatry, 162, 1414-1422.
Kauer, JA. (2004). Learning mechanisms in addiction: synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse. Annu Rev Physiol, 66, 447-475.
Lefio, LA., Villarroel, SR., Rebolledo, C., Zamorano P. & Rivas, K. (2013). Effective interventions in the problematic use of alcohol and other drugs. Rev Panam Salud Publ, 34, 257-266.
Letchworth, SR., Nader, MA., Smith, HR., Friedman, DP. & Porrino, LJ. (2001). Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus
monkeys. J Neurosci, 21, 2799-2807.
Lodge, DJ. & Grace, AA. (2006). The laterodorsal tegmentum is essential for burst firing of ventral tegmental area dopamine neurons. Proc Natl Acad Sci USA, 103, 5167-5172.
Magill, M. & Ray, LA. (2009). Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs, 70, 516-527.
Murase, S., Grenhoff J., Chouvet, G., Gonon, FG. & Svensson, T. (1993). Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci Lett, 157, 53-56.
NIDA (2004). Cómo prevenir el uso de drogas en los niños y los adolescentes. Retrieved from http://www.drugabuse.gov/es/publicaciones/como-prevenir-el-uso-de-drogas.
NIDA (2008). Las drogas, el cerebro y el comportamiento: la ciencia de la adicción. National Institute on Drug Abuse. Retrieved from http://www.drugabuse.gov/es/publicaciones/las-drogas-el-cerebro-y-el-comportamiento
NIDA (2010). Principios de tratamientos para la drogadicción: Una guía basada en las investigaciones. Retrieved from http://www.drugabuse.gov/es/publicaciones/principios-de-tratamientos-para-la-drogadiccion
Scher, LM. (2014). Sedative, Hypnotic, Anxiolytic Use Disorders. Retrieved from http://emedicine.medscape.com/article/290585-overview#showall
Schultz, W. (2002). Getting formal with dopamine and reward. Neuron, 36, 241-263.
Smedslund, G., Berg RC., Hammerstrom, KT.,Steiro, A., Leiknes, KA., Dahl, HM., & Karlsen, K. (2011). Motivational interviewing for substance abuse. Cochrane Database Syst Rev CD008063. doi:10.1002/14651858.CD008063.pub2.
Stephens, E. (2014). Opioid Toxicity. In: Medscape Reference Drugs and Diseases. Retrieved from http://emedicine.medscape.com/article/815784-overview#showall
Ungerstedt, U. (1971). Stereotaxic mapping of the monoamine pathways in the rat brain. Acta PhysiolScand Suppl, 367, 1-48.
Ungless, MA., Whistler, JL., Malenka, RC. & Bonci, A. (2001). Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature, 411, 583-587.
Volkow, ND., Chang, L., Wang, GJ., Fowler, JS., Franceschi, D., Sedler, M., Gatley, SJ., Miller, E., Hitzemann, R., Ding, YS. & Logan, J. (2001). Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci, 21, 9414-9418.
Wise, RA. (2002). Brain reward circuitry: insights from unsensed incentives. Neuron, 36, 229-240.
Wise, RA. (2009). Ventral tegmental glutamate: a role in stress-, cue-, and cocaine-induced reinstatement of cocaineseeking. Neuropharmacology 56 Suppl 1, 174-176.
Wolf, ME. (2002). Addiction: making the connection between behavioral changes and neuronal plasticity in specific pathways. Mol Interv 2, 146-157.
You, ZB., Wang, B., Zitzman, D., Azari, S., & Wise, RA. (2007). A role for conditioned ventral tegmental glutamate release in cocaine seeking. J Neurosci 27, 10546-10555.